Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease
Abstract Background Blood–brain barrier dysfunction is one characteristic of Alzheimer’s disease (AD) and is recognized as both a cause and consequence of the pathological cascade leading to cognitive decline. The goal of this study was to assess markers for barrier dysfunction in postmortem tissue...
Saved in:
| Main Authors: | Geetika Nehra, Bryan J. Maloney, Rebecca R. Smith, Wijitra Chumboatong, Erin L. Abner, Peter T. Nelson, Björn Bauer, Anika M. S. Hartz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Fluids and Barriers of the CNS |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12987-024-00615-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease
by: Futao Zhou, et al.
Published: (2024-10-01) -
Cognitive decline profiles associated with lewy pathology in the context of Alzheimer’s disease neuropathologic change
by: Jon B. Toledo, et al.
Published: (2024-12-01) -
Pengabdian Kepada Masyarakat Pengembangan Usaha Frozen Food di Denpasar Barat
by: Ni Nengah Lasmini, et al.
Published: (2023-08-01) -
Navigating Alzheimer’s Disease Mouse Models: Age-Related Pathology and Cognitive Deficits
by: Laura Maria De Plano, et al.
Published: (2024-11-01) -
Self‐Aggregating Tau Fragments Recapitulate Pathologic Phenotypes and Neurotoxicity of Alzheimer's Disease in Mice
by: Ly Thi Huong Luu Le, et al.
Published: (2023-10-01)